Achieve Life Sciences ACHV Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost at other companies
Other financials
Where this comes from
Reported directly by Achieve Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost.
The official record: Achieve Life Sciences’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Achieve Life Sciences's effective income tax rate reconciliation nondeductible expense share based compensation cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Achieve Life Sciences's effective income tax rate reconciliation nondeductible expense share based compensation cost?
- Achieve Life Sciences (ACHV) reported effective income tax rate reconciliation nondeductible expense share based compensation cost of -2% in Q4 2025.
- What does effective income tax rate reconciliation nondeductible expense share based compensation cost mean?
- This metric measures the percentage impact of nondeductible share-based compensation on the effective tax rate. It illustrates how equity compensation policies create a wedge between book income and taxable income. It is useful for assessing the tax efficiency of executive and employee incentive plans.